Loss of heterozygosity at 8p, 9p and 17q in laryngeal cytological specimens

Oral Oncol. 1998 Nov;34(6):519-23. doi: 10.1016/s1368-8375(98)00056-6.

Abstract

The activation of oncogenes and the inactivation of tumour suppressor genes play a critical role in laryngeal tumorigenesis. Recent investigations revealed that 8p, 9p and 17q arms of human chromosomes harbour tumour suppressor genes (TSGs) such as p16 and BRCA1 with an important role in the multistage carcinogenesis of the larynx. In order to investigate the implication of these novel TSGs in the development of laryngeal neoplasia we performed a loss of heterozygosity (LOH) analysis using a bank of 15 polymorphic microsatellite markers (4 at 8p21, 7 at 9p21 arm and 4 at 17q arm surrounding the BRCA1 region) in a series of 32 cytological specimens (19 squamous cell carcinoma, 13 benign lesions of the larynx). Both benign and malignant specimens exhibited genetic alterations with at least one microsatellite marker. Fifteen (47%) out of the 32 specimens exhibited LOH at 8p21, 25/32 (78%) showed LOH at 9p21 and 18/32 (56%) displayed LOH at 17q21. Genetic alterations were detected in both benign and malignant lesions for all the loci tested suggesting an important role of these regions in the development of laryngeal neoplasia. This is the first report of detection of microsatellite alterations not only in solid tumours of the larynx but in laryngeal cytological specimens, suggesting that microsatellite analysis may be a useful tool in the primary diagnosis of the disease.

MeSH terms

  • Carcinoma, Squamous Cell / genetics*
  • Genes, BRCA1 / genetics
  • Genes, p16 / genetics
  • Genetic Markers
  • Humans
  • Laryngeal Neoplasms / genetics*
  • Loss of Heterozygosity / genetics*
  • Microsatellite Repeats / genetics

Substances

  • Genetic Markers